Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

Abroad (travel likely)RecruitingPHASE1

Conditions

Colitis · Diarrhea · Malignant Genitourinary System Neoplasm · Melanoma · Lung Cancer · Ovarian Cancer · Uterine Cancer · Breast Cancer · Cervical Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

M D Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Yinghong Wang) · 713-792-7672
Contact: Principal Investigator (Yinghong Wang)

Study leads

Yinghong Wang
Principal Investigator
M.D. Anderson Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Patient Preference for Subcutaneous vs. Intravenous Immune Therapy

Renal Cell Carcinoma · Non Small Cell Lung Cancer · Melanoma

Abroad (travel likely)RecruitingPHASE2

Pittsburgh, United States

Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population

Ulcerative Colitis · Inflammatory Bowel Diseases · Clostridioides Difficile Infection

Abroad (travel likely)RecruitingPHASE1

Calgary, Canada · Edmonton, Canada

Safety and Efficacy of Fecal Microbiota Transplantation

Crohn Disease · Ulcerative Colitis · Celiac Disease

Abroad (travel likely)Recruiting

Hong Kong, Hong Kong

A Study of Single and Multiple Ascending Doses of H021 in Healthy Participants

Ulcerative Colitis

Abroad (travel likely)RecruitingPHASE1

Melbourne, Australia